Kala Pharmaceuticals Adds 6% In Morning Trade

On:

Shares of Kala Pharmaceuticals, Inc. (KALA) are rising more than 6% Friday morning at $16.43.

The company today said Combangio, Inc., a unit of Kala, has been awarded a $15 million grant by the California Institute for Regenerative Medicine (CIRM) to support the company’s ongoing study of KPI-012 for the treatment of persistent corneal epithelial defect (PCED).

KALA has traded in the range of $3.54-$56.72 in the last 1 year.

Source: Read Full Article

Lates News:
  1. BMW Thailand To Use Blockchain Technology For Daily Operations
  2. Why Wall Street Sees Bitcoin Falling Sharply To $10,000
  3. Cryptos Slide After A Brilliant Rally
  4. Bitcoin's 'BlackRock Rally' and the Surge in Coinbase Shares: An Analysis
  5. Bloomberg Strategist: Ethereum Is ‘Doing to the World What Netflix Did to Blockbuster’